Lombard Medical
Private Company
Total funding raised: $80M
Overview
Lombard Medical is a commercial-stage medical device company focused on the aortic intervention market. Its core technology is a portfolio of endovascular stent-grafts, including the Altura platform for abdominal aortic aneurysms (AAA) and the Hercules platform for thoracic aortic aneurysms (TAA), with a strong emphasis on custom, patient-specific solutions like the Meridian fenestrated system. The company appears to be integrated into the larger MicroPort Endovastec organization following an acquisition, leveraging this for global commercial reach. Its strategy targets complex aortic anatomies through ultra-low profile and customizable devices, aiming to address unmet clinical needs in vascular surgery.
Technology Platform
Platforms for endovascular aortic stent-grafts, including the ultra-low profile Altura system for AAA, the Hercules system for TEVAR, and capabilities for custom fenestrated/branched devices (Meridian, Castor).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Lombard Medical competes in the aortic stent-graft market against dominant players like Medtronic, W.L. Gore, and Cook Medical. It differentiates itself by focusing on ultra-low profile delivery systems for challenging access and patient-specific custom devices for complex anatomy, carving out a niche rather than competing directly on high-volume standard procedures.